awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27001318-D75927E4-3020-4991-BB1C-822FD1FFD54E
Q27001318-D75927E4-3020-4991-BB1C-822FD1FFD54E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27001318-D75927E4-3020-4991-BB1C-822FD1FFD54E
Immunomodulatory drugs and active immunotherapy for chronic lymphocytic leukemia
P2860
Q27001318-D75927E4-3020-4991-BB1C-822FD1FFD54E
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27001318-D75927E4-3020-4991-BB1C-822FD1FFD54E
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dc714dc9a2ee7f1dc9fbc5ae11be1977e869a304
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.